1Q17 performance

GlaxoSmithKline (GSK) reported a 19.0% rise in 1Q17 revenues to ~7.4 billion pounds, driven by an operational rise of 5.0% and a favorable currency impact of 14.0%. The growth was due to the strong performance of all segments and new pharmaceutical products and vaccines.

GlaxoSmithKline’s Segment Performances in 1Q17

The above graph shows revenues for GlaxoSmithKline over the last nine quarters. Since the company reports its financial statements in sterling pounds, and since the sterling pound weakened against all major currencies in 1Q17, foreign exchange had a positive impact on overall revenues.

Geographical performance

US markets reported an operational growth of 11.0% in 1Q17 revenues to ~2.6 billion pounds, while revenues from Europe were nearly flat at ~2.0 billion pounds. The rest of its world revenues reported a rise of 4.0% to ~2.8 billion in 1Q17.

Segmental performance

GlaxoSmithKline’s (GSK) business is divided into three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare.

Pharmaceuticals

Revenues for the Pharmaceuticals segment showed an operational growth of 4.0% to ~4.2 billion pounds in 1Q17, driven by the strong performance of its new pharmaceutical products, including Relvar Ellipta/Breo Ellipta and Nucala, and its HIV (human immunodeficiency virus) products Triumeq and Tivicay.

Vaccines

The Vaccines segment reported an operational growth of 16.0% to ~1.2 billion pounds in 1Q17, driven by the strong performance of vaccines such as Rotarix, Boostrix, Bexsero, Menveo, Infanrix, and Pediarix.

Consumer Healthcare

Consumer Healthcare revenues reported an operational growth of 2.0% to ~2.0 billion pounds, driven by wellness products and skin healthcare products.

To divest the risk, you can consider ETFs such as the iShares MSCI ACWI Ex-US (ACWX), which holds 0.60% of its total assets in GlaxoSmithKline. ACWX also holds 1.3% of its total assets in Novartis (NVS), 0.60% in Novo Nordisk (NVO), and 0.30% in Teva Pharmaceutical Industries (TEVA).

Latest articles

On Tuesday, Tesla (TSLA) cut the prices of its vehicles to standardize its global car line-up, according to Reuters.

Yesterday, PayPal (PYPL) announced that it would expand Xoom, which is its international money transfer service, to 32 markets in Europe.

Visa stock has risen about 37% and has outperformed the S&P 500 Index so far in 2019.

16 Jul

What to Expect from Skechers’s Q2 Results

WRITTEN BY Sharon Bailey

Skechers (SKX) is set to declare its results for the second quarter after the markets close on July 18. Here's what you should know.

On Tuesday, Canadian Pacific Railway (CP) reported strong second-quarter earnings. The company's top and bottom lines touched a record mark.

16 Jul

What to Expect from Crown Castle's Q2 Results

WRITTEN BY Sushree Mohanty

Crown Castle International (CCI) is scheduled to announce its second-quarter earnings results on Wednesday after the market closes.